(Q36605119)

15 August 2017

1 reference

title

Immunopathology of RSV infection: prospects for developing vaccines without this complication (English)

1 reference

Sylvia van Drunen Littel-van den Hurk

15 August 2017

author

series ordinal

1

object named as

van Drunen Littel-van den Hurk S

1 reference

15 August 2017

Mapletoft JW

2

1 reference

15 August 2017

Arsic N

series ordinal

3

1 reference

15 August 2017

Kovacs-Nolan J

series ordinal

4

1 reference

15 August 2017

publication date

1 January 2007

1 reference

Reviews in Medical Virology

15 August 2017

published in

1 reference

15 August 2017

volume

17

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

5-34

1 reference

Respiratory syncytial virus and influenza A infections in the hospitalized elderly

15 August 2017

cites work

1 reference

An Immunomodulatory GpG Oligonucleotide for the Treatment of Autoimmunity via the Innate and Adaptive Immune Systems

21 January 2018

1 reference

Dendritic cells: immune regulators in health and disease

21 January 2018

1 reference

Immunity to and frequency of reinfection with respiratory syncytial virus

21 January 2018

1 reference

Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model

21 January 2018

1 reference

Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine

21 January 2018

1 reference

A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine

21 January 2018

1 reference

Increased replication of respiratory syncytial virus (RSV) in pulmonary infiltrates is associated with enhanced histopathological disease in bonnet monkeys (Macaca radiata) pre-immunized with a formalin-inactivated RSV vaccine

21 January 2018

1 reference

Intracellular IFN-gamma expression in natural killer cells precedes lung CD8+ T cell recruitment during respiratory syncytial virus infection

21 January 2018

1 reference

The rational design of vaccine adjuvants for mucosal and neonatal immunization

21 January 2018

1 reference

Murine neonatal CD4+ lymph node cells are highly deficient in the development of antigen-specific Th1 function in adoptive adult hosts.

21 January 2018

1 reference

Vaccination of cotton rats with a chimeric FG glycoprotein of human respiratory syncytial virus induces minimal pulmonary pathology on challenge

21 January 2018

1 reference

Immunogenicity of purified F glycoprotein of respiratory syncytial virus: clinical and immune responses to subsequent natural infection in children

21 January 2018

1 reference

Respiratory syncytial virus vaccines: can we improve on nature?

21 January 2018

1 reference

Mucosal delivery of a respiratory syncytial virus CTL peptide with enterotoxin-based adjuvants elicits protective, immunopathogenic, and immunoregulatory antiviral CD8+ T cell responses

21 January 2018

1 reference

Mucosally Delivered E1-Deleted Adenoviral Vaccine Carriers Induce Transgene Product-Specific Antibody Responses in Neonatal Mice

21 January 2018

1 reference

Vaccination with recombinant alphavirus or immune-stimulating complex antigen against respiratory syncytial virus

21 January 2018

1 reference

Effective priming of neonates born to immune dams against the immunogenic pseudorabies virus glycoprotein gD by replication-incompetent adenovirus-mediated gene transfer at birth

21 January 2018

1 reference

Safety and immunogenicity of intramuscular and intravaginal delivery of HIV-1 DNA constructs to infant chimpanzees.

21 January 2018

1 reference

DNA encoding the attachment (G) or fusion (F) protein of respiratory syncytial virus induces protection in the absence of pulmonary inflammation

21 January 2018

1 reference

Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/RMV.518

1 reference

15 August 2017

1 reference